Clinical trial
Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia…
NCT00103753 · Royal Brompton & Harefield NHS Foundation Trust, Other · Unknown status
Key facts
| NCT number | NCT00103753 |
|---|---|
| Title | Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major |
| Official title | A Randomized, Placebo Controlled, Double Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance |
| Lead sponsor | Royal Brompton & Harefield NHS Foundation Trust, Other |
| Collaborators | CORDA, The Heart Charity The Cooley's Anemia Foundation, Apotex Inc. Industry The UK Thalassemia Society |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Beta-Thalassemia |
| Intervention type | Drug |
| Interventions | deferiprone |
| Enrollment | 65 |
| Start date | May 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Feb 15, 2005 |
| Last update posted | Jun 24, 2005 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: